These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 35220069)
1. Management of Early-Stage Resected Non-Small Cell Lung Cancer: Consensus Statement of the Lung cancer Consortium. Allehebi A; Kattan KA; Rujaib MA; Dayel FA; Black E; Mahrous M; AlNassar M; Hussaini HA; Twairgi AA; Abdelhafeiz N; Omair AA; Shehri SA; Al-Shamsi HO; Jazieh AR Cancer Treat Res Commun; 2022; 31():100538. PubMed ID: 35220069 [TBL] [Abstract][Full Text] [Related]
2. Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): a European survey conducted by the European Society for Medical Oncology (ESMO) young oncologists committee. Califano R; Karamouzis MV; Banerjee S; de Azambuja E; Guarneri V; Hutka M; Jordan K; Kamposioras K; Martinelli E; Corral J; Postel-Vinay S; Preusser M; Porcu L; Torri V Lung Cancer; 2014 Jul; 85(1):74-80. PubMed ID: 24746176 [TBL] [Abstract][Full Text] [Related]
3. Multi-disciplinary approach for the management of non-metastatic non-small cell lung cancer in the Middle East and Africa: Expert panel recommendations. Göker E; Altwairgi A; Al-Omair A; Tfayli A; Black E; Elsayed H; Selek U; Koegelenberg C Lung Cancer; 2021 Aug; 158():60-73. PubMed ID: 34119934 [TBL] [Abstract][Full Text] [Related]
4. Management of Stage III Non-Small-Cell Lung Cancer: ASCO Guideline. Daly ME; Singh N; Ismaila N; Antonoff MB; Arenberg DA; Bradley J; David E; Detterbeck F; Früh M; Gubens MA; Moore AC; Padda SK; Patel JD; Phillips T; Qin A; Robinson C; Simone CB J Clin Oncol; 2022 Apr; 40(12):1356-1384. PubMed ID: 34936470 [TBL] [Abstract][Full Text] [Related]
5. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Howington JA; Blum MG; Chang AC; Balekian AA; Murthy SC Chest; 2013 May; 143(5 Suppl):e278S-e313S. PubMed ID: 23649443 [TBL] [Abstract][Full Text] [Related]
6. Third CECOG consensus on the systemic treatment of non-small-cell lung cancer. Brodowicz T; Ciuleanu T; Crawford J; Filipits M; Fischer JR; Georgoulias V; Gridelli C; Hirsch FR; Jassem J; Kosmidis P; Krzakowski M; Manegold C; Pujol JL; Stahel R; Thatcher N; Vansteenkiste J; Minichsdorfer C; Zöchbauer-Müller S; Pirker R; Zielinski CC; Ann Oncol; 2012 May; 23(5):1223-1229. PubMed ID: 21940784 [TBL] [Abstract][Full Text] [Related]
7. Multidisciplinary consensus statement on the clinical management of patients with stage III non-small cell lung cancer. Majem M; Hernández-Hernández J; Hernando-Trancho F; Rodríguez de Dios N; Sotoca A; Trujillo-Reyes JC; Vollmer I; Delgado-Bolton R; Provencio M Clin Transl Oncol; 2020 Jan; 22(1):21-36. PubMed ID: 31172444 [TBL] [Abstract][Full Text] [Related]
8. Clinical management of stage III non-small cell lung cancer in India: An expert consensus statement. Batra U; Prabhash K; Agarwal JP; Darlong L; Munshi A; Penumadu P; Thangakunam B; Bansal A Asia Pac J Clin Oncol; 2023 Dec; 19(6):606-617. PubMed ID: 36815621 [TBL] [Abstract][Full Text] [Related]
9. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology. J Clin Oncol; 1997 Aug; 15(8):2996-3018. PubMed ID: 9256144 [TBL] [Abstract][Full Text] [Related]
10. Definitive and Adjuvant Radiotherapy in Locally Advanced Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline. Bezjak A; Temin S; Franklin G; Giaccone G; Govindan R; Johnson ML; Rimner A; Schneider BJ; Strawn J; Azzoli CG J Clin Oncol; 2015 Jun; 33(18):2100-5. PubMed ID: 25944914 [TBL] [Abstract][Full Text] [Related]
11. Palliative thoracic radiation therapy for non-small cell lung cancer: 2018 Update of an American Society for Radiation Oncology (ASTRO) Evidence-Based Guideline. Moeller B; Balagamwala EH; Chen A; Creach KM; Giaccone G; Koshy M; Zaky S; Rodrigues G Pract Radiat Oncol; 2018; 8(4):245-250. PubMed ID: 29625898 [TBL] [Abstract][Full Text] [Related]
12. Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline. Videtic GMM; Donington J; Giuliani M; Heinzerling J; Karas TZ; Kelsey CR; Lally BE; Latzka K; Lo SS; Moghanaki D; Movsas B; Rimner A; Roach M; Rodrigues G; Shirvani SM; Simone CB; Timmerman R; Daly ME Pract Radiat Oncol; 2017; 7(5):295-301. PubMed ID: 28596092 [TBL] [Abstract][Full Text] [Related]
13. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC). Brahmer JR; Govindan R; Anders RA; Antonia SJ; Sagorsky S; Davies MJ; Dubinett SM; Ferris A; Gandhi L; Garon EB; Hellmann MD; Hirsch FR; Malik S; Neal JW; Papadimitrakopoulou VA; Rimm DL; Schwartz LH; Sepesi B; Yeap BY; Rizvi NA; Herbst RS J Immunother Cancer; 2018 Jul; 6(1):75. PubMed ID: 30012210 [TBL] [Abstract][Full Text] [Related]
14. Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline. Schneider BJ; Daly ME; Kennedy EB; Antonoff MB; Broderick S; Feldman J; Jolly S; Meyers B; Rocco G; Rusthoven C; Slotman BJ; Sterman DH; Stiles BM J Clin Oncol; 2018 Mar; 36(7):710-719. PubMed ID: 29106810 [TBL] [Abstract][Full Text] [Related]
15. Canadian Consensus Recommendations for the Management of Operable Stage II/III Non-Small-Cell Lung Cancer: Results of a Modified Delphi Process. Tankel J; Spicer J; Chu Q; Fiset PO; Kidane B; Leighl NB; Joubert P; Maziak D; Palma D; McGuire A; Melosky B; Snow S; Bahig H; Blais N Curr Oncol; 2023 Dec; 30(12):10363-10384. PubMed ID: 38132389 [TBL] [Abstract][Full Text] [Related]
16. Asian Thoracic Oncology Research Group Expert Consensus Statement on Optimal Management of Stage III NSCLC. Tan WL; Chua KLM; Lin CC; Lee VHF; Tho LM; Chan AW; Ho GF; Reungwetwattana T; Yang JC; Kim DW; Soo RA; Ahn YC; Onishi H; Ahn MJ; Mok TSK; Tan DSW; Yang F J Thorac Oncol; 2020 Mar; 15(3):324-343. PubMed ID: 31733357 [TBL] [Abstract][Full Text] [Related]
17. ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer. Passaro A; Leighl N; Blackhall F; Popat S; Kerr K; Ahn MJ; Arcila ME; Arrieta O; Planchard D; de Marinis F; Dingemans AM; Dziadziuszko R; Faivre-Finn C; Feldman J; Felip E; Curigliano G; Herbst R; Jänne PA; John T; Mitsudomi T; Mok T; Normanno N; Paz-Ares L; Ramalingam S; Sequist L; Vansteenkiste J; Wistuba II; Wolf J; Wu YL; Yang SR; Yang JCH; Yatabe Y; Pentheroudakis G; Peters S Ann Oncol; 2022 May; 33(5):466-487. PubMed ID: 35176458 [TBL] [Abstract][Full Text] [Related]
18. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group. Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759 [TBL] [Abstract][Full Text] [Related]
19. Relevance of multi-disciplinary team approach in diagnosis and management of Stage III NSCLC. Batra U; Munshi A; Kabra V; Momi G Indian J Cancer; 2022 Mar; 59(Supplement):S46-S55. PubMed ID: 35343190 [TBL] [Abstract][Full Text] [Related]
20. Adjuvant radiation therapy in locally advanced non-small cell lung cancer: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guideline. Rodrigues G; Choy H; Bradley J; Rosenzweig KE; Bogart J; Curran WJ; Gore E; Langer C; Louie AV; Lutz S; Machtay M; Puri V; Werner-Wasik M; Videtic GMM Pract Radiat Oncol; 2015; 5(3):149-155. PubMed ID: 25957185 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]